Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis

Medical Mycology
Eric MilefchikR A Larsen

Abstract

An all oral treatment for cryptococcal meningitis is attractive, particularly where amphotericin B use is impractical. Both fluconazole and flucytosine are available in oral formulations and have activity against Cryptococcus neoformans. We conducted a prospective phase II dose escalation study employing doses of fluconazole ranging from 800 to 2000 mg daily for 10 weeks used alone or combined with flucytosine at 100 mg/kg per day for the first 4 weeks. We found that increasing doses of fluconazole were associated with an increase in survival and a decrease in the time to conversion of the cerebrospinal fluid from culture positive to culture negative. Addition of flucytosine to fluconazole improved outcomes in each dosing cohort. High doses of fluconazole alone or combined with flucytosine were well tolerated.

Citations

Jun 10, 2010·Current HIV/AIDS Reports·Arthur Jackson, Mina C Hosseinipour
May 30, 2013·Current HIV/AIDS Reports·Ana-Claire Meyer, Mark Jacobson
Feb 11, 2011·Current Infectious Disease Reports·Kyle D Brizendine, Peter G Pappas
Jun 6, 2013·The Lancet Infectious Diseases·Angela LoyseTihana Bicanic
Jan 27, 1994·The New England Journal of Medicine·J A Como, W E Dismukes
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicky LongleyThomas S Harrison
Dec 30, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jesse C NussbaumThomas S Harrison
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Manjunath P PaiLinda A Felton
Jul 10, 2009·Current Opinion in Infectious Diseases·Derek J SloanDavid G Lalloo
Oct 15, 2014·Journal of Pharmaceutical Sciences·Naseem CharooJennifer Dressman
Oct 22, 2008·Expert Opinion on Pharmacotherapy·Alicia Gómez-LópezManuel Cuenca-Estrella
Jun 22, 2013·The Journal of Antimicrobial Chemotherapy·Angela LoyseThomas S Harrison
Jan 22, 2017·Journal de mycologie médicale·G A KouakouS P Eholié
Dec 3, 2016·AIDS Research and Therapy·Sirawat Srichatrapimuk, Somnuek Sungkanuparph
Mar 8, 2018·Memórias do Instituto Oswaldo Cruz·Ahmad Mourad, John R Perfect
Jan 23, 2018·AIDS Research and Human Retroviruses·Richard A MurphyMahomed-Yunus S Moosa
Jul 26, 2018·The Cochrane Database of Systematic Reviews·Mark W TenfordeNathan Ford
Jun 20, 2018·Antimicrobial Agents and Chemotherapy·Katharine E StottWilliam Hope
Nov 4, 2008·Current Opinion in Infectious Diseases·Joseph N JarvisOlivier Lortholary
Aug 28, 2009·Expert Opinion on Pharmacotherapy·Michele Ritter, David L Goldman
Nov 19, 2019·PLoS Neglected Tropical Diseases·Fulgence Kondo KassiSébastien Bertout
Mar 4, 2011·Medical Mycology·Melanie W PoundRichard H Drew
Aug 22, 2020·Medical Mycology·Chi-Jan LinYing-Lien Chen
Dec 14, 2018·BMC Infectious Diseases·Hua-Zhen ZhaoLi-Ping Zhu
Nov 15, 2008·Revista Da Sociedade Brasileira De Medicina Tropical·Maria Luiza MorettiMaria Aparecida Shikanai-Yasuda
Jan 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R PerfectTania C Sorrell

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jesse C NussbaumThomas S Harrison
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R A LarsenJ M Leedom
The New England Journal of Medicine
Jeremy N DayJeremy J Farrar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J R PerfectTania C Sorrell
© 2022 Meta ULC. All rights reserved